Stocks
Dicerna Pharmaceuticals (DRNA) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.78 | 1.92 | 3.46 | 2.73 | 4.68 | 4.23 | |||
| Changes by years, y/y, % | -49% | +145% | +80% | -21% | +71% | +25.2% | |||
Dicerna Pharmaceuticals. Debt/EBITDA
Dicerna Pharmaceuticals. Debt/EBITDA, changes, %
Dicerna Pharmaceuticals (DRNA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | LTM ? | |||
| Debt/EBITDA | 4.91 | 4.50 | 4.13 | 4.22 | 4.23 | 4.23 | ||
| Changes by years, y/y, % | +66% | +75% | -25% | -15% | -14% | |||
| Changes by quarters, q/q, % | -1% | -8% | -8% | +2% | +0% | |||
